Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout

被引:171
作者
Dombkowski, RA
Russell, MJ
Olson, KR
机构
[1] Univ Notre Dame, S Bend Ctr Med Educ, Indiana Univ Sch Med, Notre Dame, IN 46556 USA
[2] Univ Notre Dame, Indiana Univ Sch Med, Dept Biol Sci, Notre Dame, IN 46556 USA
关键词
fish; cardiovascular; guanosine; 3; 5 '-cyclic monophosphate; vasodilator; vasoconstrictor;
D O I
10.1152/ajpregu.00419.2003
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Hydrogen sulfide (H2S) is an endogenous vasodilator in mammals, but its presence and function in other vertebrates is unknown. We generated H2S from NaHS and examined the effects on isolated efferent branchial arteries from steelhead (stEBA) or rainbow (rtEBA) trout. H2S concentration was measured colorimetrically ( CM) and with ion-selective electrodes (ISE) in rainbow trout plasma. NaHS produced a triphasic response consisting of a relaxation ( phase 1), constriction ( phase 2), and relaxation ( phase 3) in both unstimulated vessels and in stEBA precontracted with carbachol ( Carb). Phase 1 and phase 3 in stEBA were decreased and phase 2 increased in unstimulated vessels by K-ATP(+) channel inhibition ( glibenclamide), or a cocktail of inhibitors of cyclooxygenase, lipoxygenase, and cytochrome P-450 ( indomethacin, esculetin, and clotrimazole). Inhibition of soluble guanylate cyclase with ODQ or NS-2028 inhibited phase 3 in stEBA, although NaHS decreased cGMP production by rtEBA. stEBA phase 2 contractions were partially inhibited by the myosin light chain kinase inhibitor, ML-9, but unaffected by L-type calcium channel inhibition ( methoxyverapamil), whereas contraction in rtEBA was partially inhibited by nifedipine or removal of extracellular calcium. Phase 3 relaxations were more pronounced in stEBA precontracted with Carb and norepinephrine ( NE) than those contracted by KCl or K2SO4. stEBA phase 2 and phase 3 responses were dose dependent (EC50 = 1.1 +/- 1.2 x 10(-3) M and 6.7 +/- 0.9 x 10(-5) M, respectively; n = 7). NaHS was also vasoactive in steelhead bulbus arteriosus, celiacomesenteric arteries, and anterior cardinal veins. Rainbow trout plasma sulfide concentration was 4.0 +/- 0.3 x 10(-5) M, n = 4 ( CM) and 3.8 +/- 0.4 x 10(-5) M, n = 9 ( ISE); similar to phase 3 EC50. Because NaHS has substantial vasoactive effects at physiological plasma concentrations, we propose that its soluble derivative, H2S, is a tonically active endogenous vasoregulator in trout.
引用
收藏
页码:R678 / R685
页数:8
相关论文
共 24 条
[1]  
Abe K, 1996, J NEUROSCI, V16, P1066
[2]  
BRODERIUS SJ, 1976, EFFECT HYDROGEN SU 2
[3]   Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: Correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium [J].
Dorman, DC ;
Moulin, FJM ;
McManus, BE ;
Mahle, KC ;
James, RA ;
Struve, MF .
TOXICOLOGICAL SCIENCES, 2002, 65 (01) :18-25
[4]   THE OBLIGATORY ROLE OF ENDOTHELIAL-CELLS IN THE RELAXATION OF ARTERIAL SMOOTH-MUSCLE BY ACETYLCHOLINE [J].
FURCHGOTT, RF ;
ZAWADZKI, JV .
NATURE, 1980, 288 (5789) :373-376
[5]   INHIBITION OF OXYTOCIN-INDUCED BUT NOT ANGIOTENSIN-INDUCED RAT UTERINE CONTRACTIONS FOLLOWING EXPOSURE TO SODIUM SULFIDE [J].
HAYDEN, LJ ;
FRANKLIN, KJ ;
ROTH, SH ;
MOORE, GJ .
LIFE SCIENCES, 1989, 45 (26) :2557-2560
[6]   The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide [J].
Hosoki, R ;
Matsuki, N ;
Kimura, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (03) :527-531
[7]   Calcitonin gene-related peptide (CCRP), but not tachykinins, causes relaxation of small arteries from the rainbow trout gut [J].
Kågström, J ;
Holmgren, S .
PEPTIDES, 1998, 19 (03) :577-584
[8]   VIP-induced relaxation of small arteries of the rainbow trout, Oncorhynchus mykiss, involves prostaglandin synthesis but not nitric oxide [J].
Kagstrom, J ;
Holmgren, S .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1997, 63 (1-2) :68-76
[9]   VASODILATING EFFECTS OF CARBON-MONOXIDE [J].
LIN, H ;
MCGRATH, JJ .
DRUG AND CHEMICAL TOXICOLOGY, 1988, 11 (04) :371-385
[10]  
Miller VM, 1986, ACTA PHARMACOL SINIC, V21, P871